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We have reported that human immunoglobulin G (IgG) showed anti-ulcerogenic1) and anti-inflammatory2) activity after reductive cleavage of interchain disulfide bonds, though the native IgG showed no such activity. It was suggested that the chemical modification of S-S bonds in the hinge region was essential. On the other hand, we have reported the antiulcerogenic activity of various saturated3) and unsaturated4) fatty acids and investigated the relationship between alkyl or alkenyl chain lengths and biological activities.
In the present article, we describe our primary results in attempting to develop a new anti-ulcerogenic drug. As a first step, commercially available sulfur-containing amino acids and amines were chosen and their gastric secretion-inhibitory activity in pylorus-ligated rats were observed. Among the chemicals tested, cystamine showed the strongest activity. Therefore, alkenyl amino derivatives (I) were synthesized from various trans-2-unsaturated fatty acids and cystamine, and their pharmacological activities were tested together with those of the 2-(E-2-alkenoylamino)ethyl carbamoylmethyl sulfides (II) which were obtained by reduction and alkylation of the derivatives (I). 
Results

Inhibitory Effects of Various Sulfur-Containing Amino Acids and Amines on Gastric Secretion in Rats
The inhibitory effect of various samples, given at doses of 5, 10, and 25 mg/kg i.p., on gastric juice secretion in pylorus-ligated rats, was examined by measuring the volume, total acid output and total peptic activity of gastric juice, collected for 4 h during the experiment.
At a dose of 25 mg/kg i.p., all of the test sample-injected groups, except for the cysteine and cysteamine groups, showed a significant inhibition in the volume, total acid output and total peptic activity of gastric juice when compared to the control group. At a dose of 10 mg/kg i.p., only cystamine and lanthionine showed a significant gastric juice secretion-inhibitory activity; they gave 62% and 45% inhibitions of total acid output, respectively. Cystamine was more potent than lanthionine, but the difference was not significant.
Thus, cystamine was the strongest gastric secretion-inhibitory material among the various sulfur-containing amino acids and amines tested (Table I) .
Inhibitory Effects of Several Disulfides (I-1-I-9) and Sulfides (II-1 II-9) on Gastric Secretion in Rats
In order to examine the gastric juice secretion-inhibitory activity for each of the eighteen synthesized derivatives, each test sample was given intraperitoneally to rats at a dose of 25 mg/kg immediately after pylorus ligation.
All sulfides (II), which were alkylated with iodoacetamide, showed stronger activity than the disulfides (I), no matter what the length of the alkenyl chains (Table II) . The correlation between the length of the alkenyl chain of the unsaturated fatty acid in II-1-II-9 and the total acid output inhibitory activity was examined; the results are shown in Fig. 1 . Compounds 11-5 and 11-6, containing 10 or 11 carbons in the alkenyl chain of the unsaturated fatty acid, showed stronger inhibitory activity than cystamine or unsaturated fatty acid having the same carbon number alone.
We found a correlation between the pharmacological activity and the carbon number of the unsaturated fatty acid in the synthesized sulfides. Namely, the peak of gastric secretioninhibitory activity was observed at 10 or 11 carbons in the unsaturated fatty acid (Fig. 1) .
Anti-ulcer Activity of 2-(E-2-Decenoylamino)ethyl Carbamoylmethyl Sulfide (11-5) and 24E-2-Undecenoylamino) ethyl Carbamoylmethyl Sulfide (H-6) on Various Experimental Ulceration Models in Rats The effects of 11-5 and 11-6, which exhibited the strongest gastric secretion-inhibitory showed a dose-dependent decrease of the ulcer index between the dosage range from 0.5 to 5 mg/kg p.o. (Fig. 2) . The ED50 values (Fig. 2) were about 2 mg/kg (1 5 mg/kg) for 11-5 and about 1 mg/kg (0.5-2.5 mg/kg) for 11-6.
Effect of Carbon Number of Unsaturated Fatty Acid in Various Sulfides on Stress-Induced Gastric Ulceration in Rats Compounds II-1-II-9 were suspended with 10% HCO-60 solution and administered at a Each column represents percent inhibition of ulcer index in various 2-(E-2-alkenoylamino)ethyl carbamoylmethyl sulfide-treated groups against that in the control group. Each sample was administered perorally (5 mg/kg) immediately before the restraint and water-immersion stress loading. dose of 5 mg/kg p.o. to rats, which were then restrained for 7 h during water-immersion stress loading. The ulcer indices obtained are shown in Table V . The correlation between the inhibition ratio (%) of ulcer index (treated vs. control) and the alkenyl chain length of the unsaturated fatty acid in various sulfides is summarized in Fig. 3 .
The strongest inhibitory activity was observed between the carbon numbers of 10 and 11 gave the most potent activity.
Acute Toxicity Test of 11-5 and 11-6 in Mice
No deaths or toxic symptoms were observed in mice at any dose examined (p.o. or i.p.) during the experimental period. The increase of body weight was unaffected when the test samples were administered perorally. However, when the test samples were administered intraperitoneally, a slight inhibition of body weight gain was observed a few days after the sample administration in the higher dosage groups (8000 and 2000 mg/kg) of both compounds.
Discussion
We have found that reduction and alkylation of interchain disulfide bonds of native IgG result in the appearance of gastric secretion-inhibitory activity. Alkylation of thiols was necessary, because the heavy and light chains in which SH groups were left free showed no inhibitory activity.1)
In the research described in this paper, we studied the effect of modification of the SH group of simple thiol-containing amino acids and amines. Comparison of cystine and cysteine, cystamine and cysteamine indicated that the compounds which had free SH groups showed no anti-gastric secretion activity; compounds which had masked SH groups were, however, effective. Among various amino acids and amines containing a thiol, cystamine showed the strongest activity. We have already reported that trans-2-unsaturated fatty acids inhibited gastric secretion.4) Therefore, we prepared derivatives of cystamine using trans-2-unsaturated fatty acids with various chain lengths. Disulfide (I) and sulfide (II) derivatives were screened for pharmacological activity, and it was found that compounds (II) which has a carbamoylmethylated sulfide moiety showed stronger inhibitory activity than those having disulfides (I) in the stress ulceration model. Moreover, there was a relationship between the chain length of 2-alkenoic acid and the biological activity; the compounds containing a 2-alkenoic acid with a chain length of 10 to 11 carbon atoms (11-5, 11-6) showed the strongest activity.
Therefore, in the next step, we tested 11-5 and 11-6 in other experimental ulcer models induced by aspirin and HCl-ethanol. Both compounds showed potent inhibitory activity in both models. In the formation of stress-induced, pylorus-ligation and aspirin-induced ulcers, the reduction of gastric membrane defensive factors is reported to be important, in addition to the influence of gastric acid as an offensive factor.8,9) Further study will be necessary to elucidate the mechanism of action of our compounds.
These compounds also showed anti-ulcerogenic activity when the administration route was changed from peritoneal to peroral, at a dose of 20 mg/kg in the water-immersed stress model. At a dose of 5 mg/kg, both compounds showed approximately 40% inhibition, which was not statistically significant when compared with the control group. However, when dispersed in 10% HCO-60 and administered orally, both compounds showed more potent activity than when administered with 5% gum arabic. The results suggested that the compounds were better dispersed in 10% HCO-60 than 5% gum arabic and were better absorbed.
A dose-dependent decrease of ulcer index was observed in the restrained and waterimmersion stress-loaded rats at the dosage range from 0.5 to 5 mg/kg p.o. for both compounds. This activity is comparable with that of commonly used anti-peptic ulceration drugs.
Since no toxic symptoms were observed at any dose tested in mice (perorally or intraperitoneally), these derivatives may be practically useful as anti-peptic-ulceration drugs.
